Abstract:PurposeThis paper reflects on the evolution of China's drug distribution industry from the planned economy era to the most recent dramatic shift, with a major focus on the analysis of the government's efforts of centralizing the drug distribution channel through adoption of e‐bidding platforms. In a broader sense, the Chinese government's effort is a showcase of the so‐called “Chinese model” of implementing institutional change: the government initiates a project and counts on its fiat to gain compliance and support from the involved stakeholders. The purpose of this paper is to analyse the limitations and problems of this mode of implementing institutional change.Design/methodology/approachThe analytical framework draws upon Williamson's theory of the mechanism of governance and insights from new institutional economics on institutional changes. The information used in this study is based on the authors' more than 40 interviews with a variety of pharmaceutical industry stakeholders, including government agencies, hospitals, pharmaceutical manufacturers, distributors, and electronic bidding platforms providers.FindingsThe failure of implementing third party electronic platforms based drug procurement practices shows the importance of aligning the mode of governing transactions with the macro level institutional environment and the micro level individual behavioral traits, and the government's decision of taking over the ownership of transaction platforms has further corroborated this logic.Originality/valueThis paper is an effort to analyze the logic behind the Chinese model of implementing institutional change: the government initiates a project and counts on its fiat to gain compliance and support from the involved stakeholders. From the academic perspective, this paper contributes to literature on the analysis of the interaction of technology adoption and institutional change.

The Study of Performance and Operation of Pharmaceutical E-Market

Pharmaceutical E-Business In China: A Case Of A Pharmaceutical E-Commerce Company

Transforming Inter-Organizational Information Systems into Electronic Commerce Marketplaces: Development of B2B Electronic Commerce in China’s Pharmaceutical Industry

A Value Chain Based Analysis of Electronic Commerce's Transformation of China 's Pharmaceutical Industry

A brief analysis of favorable and unfavorable conditions for future development of pharmaceutical E-commerce in China

A Legal Analysis on the Current Trade Status of Traditional Chinese Medicinal Product in the E.U. — From the Perspectives of WTO Law and E.U. Pharmaceutical Law

A Performance Evaluation Framework of Electricity Markets in China

A Study On The Development Of Agricultural E-Marketplaces

Health in China. the Healthcare Market.

Analysis of Influencing Factors on Doctor's Prescription Behavior in China

An Evaluation Model And Empirical Study Of Distributors' Performance In Chinese Mobile Industry

Government Driven Model of Institutional Change Through Adoption of New Technology A Case Study of the Failed Pharmaceutical Bidding and Procurement Platforms in China

Study on the Operational Environment of E-Commerce in China

Problems and Reform Strategies of Medicines Distribution System in China

Present Situation and Thinking of Pharmaceutical Distribution System in China

Delivery efficiency and supplier performance evaluation in China’s E-retailing industry

Research on Consumer Satisfaction in Pharmaceutical E-commerce based on Review Texts

Analysis of e-commerce application in pharmaceutical enterprises—A case study of Yaofang.cn

Network Relations and Boundary Spanning: Understanding the Evolution of E-Ordering in the Chinese Drug Distribution Industry

Study on the Key Factors of Impacting E-Ra Result

THE EVALUATION MODEL AND EMPIRICAL STUDY OF DISTRIBUTORS' PERFORMANCE IN CHAIN MOBILE INDUSTRY